Daily low dose thalidomide plus monthly high-dose dexamethasoneas consolidation/maintenance treatment in elderly multiple myeloma patients

被引：0
|
作者：
Gentile, M.
Mazzone, C.
Iorio, C.
Lucia, E.
Vigna, E.
Mazzei, F.
Carnevale, P.
Bisconte, M. G.
Gentile, C.
Morabito, F.
机构：
[1] Haematol Unit, Cosenza, Italy
[2] Pharm Unit, Cosenza, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0255
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [41] High-dose therapy in multiple myeloma
    Harousseau, JL
    ANNALS OF ONCOLOGY, 2002, 13 : 49 - 54
  • [42] Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment
    Vaxman, Iuliana
    Al Saleh, Abdullah S.
    Kumar, Shaji
    Nitin, Mishra
    Dispenzieri, Angela
    Buadi, Francis
    Dingli, David
    Lacy, Martha
    Muchtar, Eli
    Hobbs, Miriam
    Fonder, Amie
    Hwa, Lisa
    Visram, Alissa
    Kapoor, Prashant
    Siddiqui, Mustaqeem
    Lust, John
    Kyle, Robert
    Rajkumar, Vincent
    Hayman, Suzanne
    Leung, Nelson
    Gonsalves, Wilson
    Kourelis, Taxiarchis
    Warsame, Rahma
    Gertz, Morie A.
    CANCER MEDICINE, 2020, 9 (23): : 8895 - 8901
  • [43] Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma
    Fassas, ABT
    Desikan, KR
    Siegel, D
    Golper, TA
    Munshi, NC
    Barlogie, B
    Tricot, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) : 938 - 941
  • [44] Low-dose thalidomide in the treatment of refractory myeloma
    Pini, M
    Baraldi, A
    Pietrasanta, D
    Allione, B
    Depaoli, L
    Salvi, F
    Levis, A
    HAEMATOLOGICA, 2000, 85 (10) : 1111 - 1112
  • [45] Low dose thalidomide maintenance in myeloma patients after autologous stem cell transplantation
    Bayer, R. -L.
    John, V.
    Devoe, C.
    Cannon, M.
    Klocke, J.
    Gissinger, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 53 - 54
  • [46] High-dose sequential chemotherapy in the treatment of multiple myeloma.
    Canales, M
    Ojeda, E
    Jiménez, V
    Jiménez, MT
    Hernández, D
    Alvárez, MT
    Martín, MP
    Bustos, JG
    Aguado, MJ
    Navarro, FH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S205 - S205
  • [47] LOW-DOSE THALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kohei, K. O.
    Ando, S.
    Hasino, S.
    Huse, H.
    Morita, R.
    Takahata, M.
    Onozawa, M.
    Kahata, K.
    Kondo, T.
    Ota, S.
    Kawamura, T.
    Kurosawa, M.
    Aikawa, K.
    Ogawa, T.
    Suzuki, S.
    Takahashi, S.
    Izumiyama, K.
    Iwasaki, H.
    Maemori, M.
    Sakai, H.
    Asaka, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 619 - 620
  • [48] The role of high-dose chemotherapy in the treatment of multiple myeloma: A controversy
    Kyle, RA
    ANNALS OF ONCOLOGY, 2000, 11 : 55 - 58
  • [49] High-dose therapy and innovative approaches to treatment of multiple myeloma
    Barlogie, B
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 21 - 27
  • [50] Low-dose thalidomide in patients with advanced, refractory multiple myeloma.
    Chen, CI
    Adesanya, A
    Sutton, DM
    Brandwein, J
    Stewart, AK
    BLOOD, 1999, 94 (10) : 308B - 308B
12345